Can Data Help Build Healthcare’s Equitable Future?
To prevent further harm and ensure families aren’t left behind again, we must use data…
Can Data Help Build Healthcare’s Equitable Future?
To prevent further harm and ensure families aren’t left behind again, we must use data more proactively — not only to close gaps in coverage but also to support accountability in how care continuity is managed. The post Can Data Help Build Healthcare’s Equitable Future? appeared first on MedCity News.
Immune Support on Demand: Ranking the Top Mobile IV Therapy Companies
[Sponsored] Explore the top mobile IV therapy companies boosting immune health on demand, with standout services, expert care and innovative delivery across the U.S. The post Immune Support on Demand: Ranking the Top Mobile IV Therapy Companies appeared first on MedCity News.
“Here, There and Everywhere”: Vendor Risks in the Health Care Sector
As healthcare continues to become more and more dependent on third-party vendor services, provider and technology entities must remain focused on the risks that their vendors present. The post “Here, There and Everywhere”: Vendor Risks in the Health Care Sector appeared first on MedCity News.
Few Trust Most Health Content on Social Media, Autism Claims Follow Thimerosal Policy Shift, and Misleading Narratives About SSRIs in Pregnancy — The Monitor
This volume analyzes findings from the latest KFF Tracking Poll on Health Information and Trust, which show that just over half of adults say they use social media to find health information and advice, but less than half trust the health content they see across an array of social media sites and apps. It also…
Healthcare Benefit Trends Report: Managers Shift to More Independent Navigation, Embrace GLP-1 Drugs with Restrictions
[Sponsored] The 2025 Benefits Sentiment Index, a survey of 120 benefit consultants to self-insured employers, focuses on healthcare navigation, GLP-1 drug coverage and AI trends for healthcare benefits. The post Healthcare Benefit Trends Report: Managers Shift to More Independent Navigation, Embrace GLP-1 Drugs with Restrictions appeared first on MedCity News.
‘A Fear Pandemic’: Immigration Raids Push Patients Into Telehealth
Jacob Sweidan has seen his patients through the federal immigration raids of the 1990s, a sitting governor’s call to abolish birthright citizenship, and the highly publicized workplace crackdowns and family separation policies of President Donald Trump’s first term. But in his 40 years as a pediatrician in Southern California serving those too poor to afford…
‘Alternative Facts’ Aren’t a Reason To Skip Vaccines
President Donald Trump’s administrations have been notorious for an array of “alternative facts” — ranging from the relatively minor (the size of inaugural crowds) to threats to U.S. democracy, such as who really won the 2020 election. And over the past six months, the stakes have been life or death: Trump’s health officials have been…
Pandemia de miedo: redadas de inmigración empujan a pacientes a la telemedicina
Jacob Sweidan ha visto a sus pacientes superar las redadas federales de inmigración de la década de 1990, el pedido de un gobernador para abolir la ciudadanía por nacimiento y las muy publicitadas medidas represivas en el lugar de trabajo y las políticas de separación familiar del primer mandato del presidente Donald Trump. Pero en…
Which Platform of Platforms (UDHP) is Right for your Health System? A Market Analysis
Neil Jennings Vince Kuraitis By NEIL JENNINGS & VINCE KURAITIS This entry is part 5 of 5 in the series Platforming Healthcare — The Long View In previous posts in this series, we have covered the definitions of Unified Digital Health platforms and whether “EHRs can become UDHPs.” In this follow-on post, we’ll talk through the requirements for…
Response Pharma’s Novel Pill for Weight Loss Shows Promise as Post-GLP-1 Maintenance Therapy
Response Pharmaceuticals takes a new approach to weight loss with an oral small molecule designed to inhibit a protein called iMTP to reduce uptake of fats and cholesterol. While this drug’s lead indication is addressing weight gain in patients taking antipsychotics, the company is also exploring other metabolic indications such as patients who need a…
